Lido Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.47M Sell
31,566
-413
-1% -$32.3K 0.01% 492
2025
Q1
$2.32M Buy
31,979
+12,337
+63% +$894K 0.01% 479
2024
Q4
$1.45M Sell
19,642
-462,216
-96% -$34.2M 0.01% 573
2024
Q3
$13.6M Buy
481,858
+464,414
+2,662% +$13.1M 0.07% 149
2024
Q2
$1.61M Buy
17,444
+1,559
+10% +$144K 0.01% 462
2024
Q1
$1.52M Sell
15,885
-22
-0.1% -$2.1K 0.01% 470
2023
Q4
$1.21M Sell
15,907
-54
-0.3% -$4.12K 0.01% 501
2023
Q3
$1.11M Sell
15,961
-2,217
-12% -$154K 0.01% 470
2023
Q2
$1.71M Buy
18,178
+1,710
+10% +$161K 0.01% 371
2023
Q1
$1.36M Buy
16,468
+8,573
+109% +$709K 0.01% 381
2022
Q4
$589K Buy
7,895
+484
+7% +$36.1K 0.01% 480
2022
Q3
$612K Buy
7,411
+198
+3% +$16.4K 0.01% 444
2022
Q2
$685K Buy
7,213
+144
+2% +$13.7K 0.01% 388
2022
Q1
$832K Sell
7,069
-1,111
-14% -$131K 0.01% 391
2021
Q4
$1.06M Buy
8,180
+659
+9% +$85.3K 0.01% 366
2021
Q3
$851K Buy
7,521
+531
+8% +$60.1K 0.01% 394
2021
Q2
$724K Buy
6,990
+1
+0% +$104 0.01% 394
2021
Q1
$585K Buy
6,989
+77
+1% +$6.45K 0.01% 411
2020
Q4
$630K Buy
6,912
+363
+6% +$33.1K 0.01% 379
2020
Q3
$523K Buy
6,549
+12
+0.2% +$958 0.01% 325
2020
Q2
$452K Buy
6,537
+33
+0.5% +$2.28K 0.01% 322
2020
Q1
$409K Sell
6,504
-1,353
-17% -$85.1K 0.02% 323
2019
Q4
$611K Buy
7,857
+2,766
+54% +$215K 0.02% 302
2019
Q3
$373K Buy
5,091
+1,215
+31% +$89K 0.02% 356
2019
Q2
$238K Buy
3,876
+18
+0.5% +$1.11K 0.01% 427
2019
Q1
$246K Buy
+3,858
New +$246K 0.02% 402
2018
Q4
Sell
-4,368
Closed -$253K 422
2018
Q3
$253K Buy
+4,368
New +$253K 0.02% 355
2017
Q3
Sell
-7,215
Closed -$284K 293
2017
Q2
$284K Sell
7,215
-237
-3% -$9.33K 0.06% 188
2017
Q1
$273K Buy
+7,452
New +$273K 0.08% 173
2016
Q3
Sell
-10,800
Closed -$359K 167
2016
Q2
$359K Sell
10,800
-4,200
-28% -$140K 0.11% 92
2016
Q1
$441K Buy
+15,000
New +$441K 0.15% 64